"
Team:Paris Bettencourt
From 2013.igem.org
(Difference between revisions)
| Line 246: | Line 246: | ||
<div class="cont"><p style=" font-size:30px;line-height:32px;">FIGHT TUBERCULOSIS WITH MODERN WEAPONS </p></div> | <div class="cont"><p style=" font-size:30px;line-height:32px;">FIGHT TUBERCULOSIS WITH MODERN WEAPONS </p></div> | ||
<div class="cont"> | <div class="cont"> | ||
| + | <p> | ||
Tuberculosis is an infectious disease caused by <i>Mycobacterium tuberculosis</i> affecting millions of people over the world. Using <i>Escherichia coli</i> as a model organism we are developing different approaches that could contribute to the fight against TB. | Tuberculosis is an infectious disease caused by <i>Mycobacterium tuberculosis</i> affecting millions of people over the world. Using <i>Escherichia coli</i> as a model organism we are developing different approaches that could contribute to the fight against TB. | ||
| + | </p> | ||
</div> | </div> | ||
<div id="psdesc" class="spdesc"> | <div id="psdesc" class="spdesc"> | ||
<div class="cont"> | <div class="cont"> | ||
| - | A biosensor that detects the presence of sequence specific antibiotic resistance genes. | + | <p>A biosensor that detects the presence of sequence specific antibiotic resistance genes.</p> |
</div> | </div> | ||
</div> | </div> | ||
<div id="dsdesc" class="spdesc"> | <div id="dsdesc" class="spdesc"> | ||
<div class="cont"> | <div class="cont"> | ||
| - | A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins. | + | <p>A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.</p> |
</div> | </div> | ||
</div> | </div> | ||
<div id="thdesc" class="spdesc"> | <div id="thdesc" class="spdesc"> | ||
<div class="cont"> | <div class="cont"> | ||
| - | A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins. | + | <p>A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.</p> |
</div> | </div> | ||
</div> | </div> | ||
<div id="tcdesc" class="spdesc"> | <div id="tcdesc" class="spdesc"> | ||
<div class="cont"> | <div class="cont"> | ||
| - | An <i>E. coli</i> which invades macrophages and kills mycobacteria. | + | <p>An <i>E. coli</i> which invades macrophages and kills mycobacteria.</p> |
</div> | </div> | ||
</div> | </div> | ||
Revision as of 22:05, 22 September 2013
FIGHT TUBERCULOSIS WITH MODERN WEAPONS
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis affecting millions of people over the world. Using Escherichia coli as a model organism we are developing different approaches that could contribute to the fight against TB.
A biosensor that detects the presence of sequence specific antibiotic resistance genes.
A safe and specific high-throughput drug screening method that targets essential mycobacterial metabolic proteins.
A phage system with low fitness cost producing sRNA, which inhibit the synthesis of antibiotic resistance proteins.
An E. coli which invades macrophages and kills mycobacteria.
Visit our Results!
Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
+33 1 44 41 25 22/25
team2013@igem-paris.org
+33 1 44 41 25 22/25
team2013@igem-paris.org 
